78 studies found for:    AMYOTROPHIC LATERAL SCLEROSIS 15, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA
Show Display Options
Rank Status Study
1 Completed
Has Results
Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal Dementia
Conditions: Frontal Lobe Dementia;   Frontotemporal Lobe Dementia;   Semantic Dementia
Interventions: Drug: memantine;   Drug: Placebo pill
2 Recruiting Characterization of Inclusion Body Myopathy Associated With Paget's Disease of Bone and Frontotemporal Dementia (IBMPFD)
Conditions: Inclusion Body Myopathy With Early-onset Paget Disease and Frontotemporal Dementia;   Paget Disease of Bone;   Frontotemporal Dementia;   Myopathy
Intervention:
3 Completed Oxytocin and Social Cognition in Frontotemporal Dementia
Conditions: Frontotemporal Dementia;   Pick's Disease
Intervention: Drug: intranasal oxytocin
4 Completed A Pilot Study to Explore the Safety and Tolerability of Galantamine HBr in the Treatment of Pick Complex/Frontotemporal Dementia
Conditions: Frontotemporal Dementia;   Pick Complex
Intervention: Drug: galantamine hydrobromide
5 Completed Open Label Pilot Study of the Effects of Memantine on FDG-PET in Frontotemporal Dementia
Condition: Frontotemporal Dementia
Intervention: Drug: memantine hydrochloride
6 Completed Safety Study of Intranasal Oxytocin in Frontotemporal Dementia
Condition: Frontotemporal Dementia
Interventions: Drug: oxytocin;   Drug: Saline Nasal Mist
7 Completed Serotonergic Function and Behavioural and Psychological Symptoms of Frontotemporal Dementia
Condition: Frontotemporal Dementia
Intervention: Drug: Citalopram
8 Terminated Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Conditions: Frontotemporal Dementia;   Amyotrophic Lateral Sclerosis
Intervention:
9 Recruiting Impact of Emotional Mimicry and Oxytocin on Frontotemporal Dementia
Condition: Frontotemporal Dementia
Interventions: Drug: Intranasal oxytocin;   Drug: Saline Nasal Mist
10 Unknown  Study of Social Behavior and Emotion in Frontotemporal Dementia, Alzheimer's Disease and Controls
Conditions: Frontotemporal Dementia;   Frontotemporal Degeneration;   Alzheimer's Disease;   Social Behavior
Intervention:
11 Recruiting Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
Condition: Behavioral Variant Frontotemporal Dementia (bvFTD)
Interventions: Drug: TRx0237;   Drug: Placebo
12 Completed Imaging Characteristics of Florbetapir 18F in Patients With Frontotemporal Dementia, Alzheimer's Disease and Normal Controls.
Conditions: Alzheimer's Disease;   Frontotemporal Dementia
Interventions: Drug: florbetapir 18F;   Drug: 18F-FDG
13 Recruiting Genetics of ALS: Identification of Genes With Roles in Familial and Sporadic Amyotrophic Lateral Sclerosis (ALS) and Amyotrophic Lateral Sclerosis (ALS) With Frontotemporal Dementia
Conditions: Amyotrophic Lateral Sclerosis;   Familial Amyotrophic Lateral Sclerosis;   Amyotrophic Lateral Sclerosis With Frontotemporal Dementia;   Lou Gehrig's Disease;   Motor Neuron Disease;   Primary Lateral Sclerosis
Intervention: Other: Genetic study of ALS families
14 Completed Direct Current Brain Polarization in Frontotemporal Dementia
Condition: Pick Disease of the Brain
Intervention: Procedure: Direct Current Polarization
15 Completed Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Conditions: Alzheimer's Disease;   Mild Cognitive Impairment;   Vascular Dementia;   Fronto-temporal Dementia;   Primary Progressive Aphasia;   Parkinson' Disease Dementia;   Mixed Dementia
Intervention:
16 Unknown  Far Infrared Irradiation for the Management, Control and Treatment of Frontotemporal Dementia
Condition: Pick Disease of the Brain
Intervention: Radiation: Radiation: Far Infrared Radiation (5μm to 20μm wavelength)
17 Active, not recruiting Computational Tools for Early Diagnosis of Memory Disorders
Conditions: Alzheimer Disease;   Frontotemporal Dementia;   Dementia, Vascular;   Mild Cognitive Impairment
Intervention:
18 Completed Study Evaluating TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Intervention: Drug: TCH346
19 Recruiting Young Onset Dementia - the Difficult Diagnosis and the Stressful Life for the Whole Family
Conditions: Frontotemporal Dementia;   Alzheimer's Disease.
Intervention:
20 Enrolling by invitation A Composite MR Neuroimaging Marker for Alzheimer's Disease
Conditions: Alzheimer's Disease;   Mild Cognitive Impairment;   Frontotemporal Dementia
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years